This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts downgraded five stocks on Thursday: Pentair (Buy to Hold), Intellia Therapeutics (Peer Perform to Underperform), Etsy (Buy to Neutral), Nutrien (Buy to Hold), and Ionis Pharmaceuticals (Outperform to Peer Perform). The changes reflect revised outlooks and price target adjustments by firms including Stifel, Wolfe Research, BTIG, and Jefferies.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Stifel analyst Nathan Jones downgraded Pentair PLC (NYSE:PNR) from Buy to Hold and cut the price target from $103 to $65. Pentair shares closed at $64.33 on Wednesday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen downgraded Intellia Therapeutics Inc (NASDAQ:NTLA) from Peer Perform to Underperform and announced a $9 price target. Intellia Therapeutics shares closed at $13.04 on Wednesday. See how other analysts view this stock.
- BTIG analyst Marvin Fong downgraded Etsy Inc (NYSE:ETSY) from Buy to Neutral. Etsy shares closed at $85.74 on Wednesday. See how other analysts view this stock.
- Jefferies analyst Laurence Alexander downgraded Nutrien Ltd (NYSE:NTR) from Buy to Hold and slashed the price target from $96 to $63. Nutrien shares closed at $68.33 on Tuesday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen downgraded Ionis Pharmaceuticals Inc (NASDAQ:IONS) from Outperform to Peer Perform. Ionis Pharmaceuticals shares closed at $54.73 on Wednesday. See how other analysts view this stock.
Considering buying ETSY stock? Here’s what analysts think:
Photo via Shutterstock